Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy
2022 · Science Translational Medicine · 58 citations
https://doi.org/10.1126/scitranslmed.abj2177
S
Shiqi Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
952
Citations
12
h-index
12
i10-index
Shiqi Yang is an academic researcher from Nanchang University. The author has contributed to research in topics: Retinal Diseases and Treatments & Retinal Development and Disorders & Retinal Imaging and Analysis. The author has an h-index of 12, co-authored 30 publications.
ORCID: 0000-0003-1314-951XPapers by this author
worksCan cardiovascular health and its modifiable healthy lifestyle offset the increased risk of all-cause and cardiovascular deaths associated with insulin resistance?
2025 · Cardiovascular Diabetology · 8 citations
https://doi.org/10.1186/s12933-025-02674-z
Efficacy and Safety of Efdamrofusp Alfa with Personalized Dosing Intervals in Neovascular Age-Related Macular Degeneration: A Phase II Trial
2025 · Ophthalmology Science · 1 citations
https://doi.org/10.1016/j.xops.2025.100913
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat